nodes	percent_of_prediction	percent_of_DWPC	metapath
WF10—CD163—mammary gland—lung cancer	0.0637	0.134	CbGeAlD
WF10—CD163—respiratory system—lung cancer	0.0425	0.0893	CbGeAlD
WF10—MAEA—respiratory system—lung cancer	0.0379	0.0796	CbGeAlD
WF10—CD163—bronchus—lung cancer	0.035	0.0735	CbGeAlD
WF10—MAEA—epithelium—lung cancer	0.0316	0.0665	CbGeAlD
WF10—CD163—trachea—lung cancer	0.0314	0.066	CbGeAlD
WF10—MAEA—bronchus—lung cancer	0.0312	0.0655	CbGeAlD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—COL4A2—lung cancer	0.0307	0.36	CbGpPWpGaD
WF10—CD163—cardiac atrium—lung cancer	0.0295	0.062	CbGeAlD
WF10—MAEA—trachea—lung cancer	0.028	0.0588	CbGeAlD
WF10—MAEA—cardiac atrium—lung cancer	0.0263	0.0552	CbGeAlD
WF10—CD163—bone marrow—lung cancer	0.0249	0.0523	CbGeAlD
WF10—CD163—lung—lung cancer	0.0226	0.0474	CbGeAlD
WF10—MAEA—bone marrow—lung cancer	0.0222	0.0466	CbGeAlD
WF10—CD163—Scavenging of heme from plasma—APOA1—lung cancer	0.0218	0.255	CbGpPWpGaD
WF10—Haemolysis—Cisplatin—lung cancer	0.0215	0.049	CcSEcCtD
WF10—MAEA—lung—lung cancer	0.0201	0.0422	CbGeAlD
WF10—CD163—Scavenging of heme from plasma—ALB—lung cancer	0.0173	0.202	CbGpPWpGaD
WF10—Extravasation—Teniposide—lung cancer	0.0165	0.0376	CcSEcCtD
WF10—CD163—lymph node—lung cancer	0.0154	0.0324	CbGeAlD
WF10—Lung disorder—Topotecan—lung cancer	0.0151	0.0343	CcSEcCtD
WF10—Lung disorder—Erlotinib—lung cancer	0.0149	0.034	CcSEcCtD
WF10—MAEA—lymph node—lung cancer	0.0137	0.0289	CbGeAlD
WF10—Lung disorder—Vinorelbine—lung cancer	0.0129	0.0294	CcSEcCtD
WF10—Venous thrombosis—Cisplatin—lung cancer	0.0127	0.0288	CcSEcCtD
WF10—Extravasation—Vinblastine—lung cancer	0.0126	0.0287	CcSEcCtD
WF10—Extravasation—Topotecan—lung cancer	0.0122	0.0279	CcSEcCtD
WF10—Phlebitis—Teniposide—lung cancer	0.0121	0.0276	CcSEcCtD
WF10—Venous thrombosis—Paclitaxel—lung cancer	0.0114	0.0259	CcSEcCtD
WF10—Fluid overload—Cisplatin—lung cancer	0.011	0.025	CcSEcCtD
WF10—Lung disorder—Irinotecan—lung cancer	0.0106	0.0242	CcSEcCtD
WF10—Extravasation—Vinorelbine—lung cancer	0.0105	0.0238	CcSEcCtD
WF10—Phlebitis—Vinblastine—lung cancer	0.00925	0.0211	CcSEcCtD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—lung cancer	0.0087	0.102	CbGpPWpGaD
WF10—Extravasation—Irinotecan—lung cancer	0.00862	0.0197	CcSEcCtD
WF10—Extravasation—Gemcitabine—lung cancer	0.0084	0.0191	CcSEcCtD
WF10—Extravasation—Cisplatin—lung cancer	0.00783	0.0178	CcSEcCtD
WF10—Phlebitis—Vinorelbine—lung cancer	0.00769	0.0175	CcSEcCtD
WF10—Extravasation—Etoposide—lung cancer	0.00717	0.0163	CcSEcCtD
WF10—Extravasation—Paclitaxel—lung cancer	0.00703	0.016	CcSEcCtD
WF10—Oedema—Crizotinib—lung cancer	0.00694	0.0158	CcSEcCtD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—ALB—lung cancer	0.00689	0.0807	CbGpPWpGaD
WF10—Infection—Crizotinib—lung cancer	0.00689	0.0157	CcSEcCtD
WF10—Hyponatraemia—Vinorelbine—lung cancer	0.00665	0.0152	CcSEcCtD
WF10—Oedema—Pemetrexed—lung cancer	0.00634	0.0144	CcSEcCtD
WF10—Infection—Pemetrexed—lung cancer	0.0063	0.0144	CcSEcCtD
WF10—Infection—Gefitinib—lung cancer	0.00626	0.0143	CcSEcCtD
WF10—Venous thrombosis—Doxorubicin—lung cancer	0.00601	0.0137	CcSEcCtD
WF10—Extravasation—Docetaxel—lung cancer	0.00596	0.0136	CcSEcCtD
WF10—Phlebitis—Cisplatin—lung cancer	0.00576	0.0131	CcSEcCtD
WF10—Hyponatraemia—Irinotecan—lung cancer	0.00548	0.0125	CcSEcCtD
WF10—Body temperature increased—Crizotinib—lung cancer	0.00548	0.0125	CcSEcCtD
WF10—Lung disorder—Methotrexate—lung cancer	0.0053	0.0121	CcSEcCtD
WF10—Phlebitis—Etoposide—lung cancer	0.00527	0.012	CcSEcCtD
WF10—Phlebitis—Paclitaxel—lung cancer	0.00517	0.0118	CcSEcCtD
WF10—Oedema—Teniposide—lung cancer	0.00513	0.0117	CcSEcCtD
WF10—Infection—Teniposide—lung cancer	0.0051	0.0116	CcSEcCtD
WF10—Body temperature increased—Pemetrexed—lung cancer	0.00501	0.0114	CcSEcCtD
WF10—Hyponatraemia—Cisplatin—lung cancer	0.00498	0.0113	CcSEcCtD
WF10—Body temperature increased—Gefitinib—lung cancer	0.00498	0.0113	CcSEcCtD
WF10—Lung disorder—Doxorubicin—lung cancer	0.00459	0.0105	CcSEcCtD
WF10—Hyponatraemia—Paclitaxel—lung cancer	0.00447	0.0102	CcSEcCtD
WF10—Phlebitis—Docetaxel—lung cancer	0.00438	0.00999	CcSEcCtD
WF10—Extravasation—Methotrexate—lung cancer	0.0043	0.00979	CcSEcCtD
WF10—Body temperature increased—Teniposide—lung cancer	0.00406	0.00925	CcSEcCtD
WF10—Hyponatraemia—Docetaxel—lung cancer	0.00379	0.00864	CcSEcCtD
WF10—Infection—Topotecan—lung cancer	0.00378	0.00862	CcSEcCtD
WF10—Oedema—Erlotinib—lung cancer	0.00377	0.00858	CcSEcCtD
WF10—Infection—Erlotinib—lung cancer	0.00374	0.00852	CcSEcCtD
WF10—Extravasation—Doxorubicin—lung cancer	0.00372	0.00848	CcSEcCtD
WF10—Infection—Vinorelbine—lung cancer	0.00323	0.00737	CcSEcCtD
WF10—Body temperature increased—Topotecan—lung cancer	0.00301	0.00686	CcSEcCtD
WF10—Body temperature increased—Erlotinib—lung cancer	0.00298	0.00678	CcSEcCtD
WF10—Phlebitis—Doxorubicin—lung cancer	0.00274	0.00623	CcSEcCtD
WF10—Oedema—Irinotecan—lung cancer	0.00268	0.00612	CcSEcCtD
WF10—Infection—Irinotecan—lung cancer	0.00267	0.00608	CcSEcCtD
WF10—Oedema—Gemcitabine—lung cancer	0.00262	0.00596	CcSEcCtD
WF10—Infection—Gemcitabine—lung cancer	0.0026	0.00592	CcSEcCtD
WF10—Body temperature increased—Vinorelbine—lung cancer	0.00257	0.00586	CcSEcCtD
WF10—Oedema—Cisplatin—lung cancer	0.00244	0.00555	CcSEcCtD
WF10—Infection—Cisplatin—lung cancer	0.00242	0.00552	CcSEcCtD
WF10—Hyponatraemia—Doxorubicin—lung cancer	0.00237	0.00539	CcSEcCtD
WF10—Infection—Etoposide—lung cancer	0.00222	0.00506	CcSEcCtD
WF10—Oedema—Paclitaxel—lung cancer	0.00219	0.00499	CcSEcCtD
WF10—Infection—Paclitaxel—lung cancer	0.00218	0.00496	CcSEcCtD
WF10—Body temperature increased—Irinotecan—lung cancer	0.00212	0.00484	CcSEcCtD
WF10—Body temperature increased—Gemcitabine—lung cancer	0.00207	0.00471	CcSEcCtD
WF10—Body temperature increased—Cisplatin—lung cancer	0.00193	0.00439	CcSEcCtD
WF10—Oedema—Docetaxel—lung cancer	0.00186	0.00423	CcSEcCtD
WF10—Infection—Docetaxel—lung cancer	0.00184	0.0042	CcSEcCtD
WF10—Body temperature increased—Etoposide—lung cancer	0.00177	0.00402	CcSEcCtD
WF10—Body temperature increased—Paclitaxel—lung cancer	0.00173	0.00394	CcSEcCtD
WF10—Body temperature increased—Docetaxel—lung cancer	0.00147	0.00334	CcSEcCtD
WF10—Infection—Methotrexate—lung cancer	0.00133	0.00303	CcSEcCtD
WF10—Oedema—Doxorubicin—lung cancer	0.00116	0.00264	CcSEcCtD
WF10—Infection—Doxorubicin—lung cancer	0.00115	0.00262	CcSEcCtD
WF10—Body temperature increased—Methotrexate—lung cancer	0.00106	0.00241	CcSEcCtD
WF10—Body temperature increased—Doxorubicin—lung cancer	0.000916	0.00209	CcSEcCtD
